← Back to Search

Protein-rich Diet and Exercise for Aging Muscles

N/A
Waitlist Available
Led By Chad Carroll, PhD
Research Sponsored by Purdue University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Women with HbA1c less than 6.5% (non-diabetic)
Women 60-80 years old.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 weeks
Awards & highlights

Study Summary

This trial will compare the effects of consuming a healthy, protein-rich diet emphasizing lean beef, compared to a healthy, normal-protein, lower beef diet (control 1), and a healthy protein-rich, lower beef diet emphasizing non-beef/red meat protein (control 2) on resistance training-induced changes in muscle and tendon tissue size, strength, and quality in older women.

Who is the study for?
This trial is for women aged 60-80 with a BMI under 40 and non-diabetic HbA1c levels. Participants must be able to do resistance training exercises but can't join if they regularly take painkillers, use tobacco, have claustrophobia or metal implants that prevent MRI scans, or any orthopedic issues affecting exercise.Check my eligibility
What is being tested?
The study tests the effects of a protein-rich diet with lean beef on muscle and tendon strength during resistance training in older women. It compares this diet to two controls: one with normal-protein and lower beef intake, and another emphasizing non-beef proteins.See study design
What are the potential side effects?
While not explicitly stated, potential side effects may include typical risks associated with dietary changes such as digestive discomfort. Resistance training could lead to muscle soreness or injury if not performed correctly.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My HbA1c level is below 6.5%, indicating I am not diabetic.
Select...
I am a woman aged between 60 and 80.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patellar Tendon Size
Skeletal Muscle Mass
Skeletal Muscle Strength
+1 more
Secondary outcome measures
Blood glucose
Cholesterol
HbA1c
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Group I: normal protein dietExperimental Treatment1 Intervention
The normal protein diet (Control) will contain the RDA for protein of (0.8 g/kg/d), with the protein provided from a variety of animal and plant-based sources, including lean beef (one 3-oz portion per week), chicken, eggs, dairy, beans, grains, nuts, seeds.
Group II: a protein-rich diet non-red meatExperimental Treatment1 Intervention
High-protein group from a variety of animal and plant-based sources (excluding additional red meats).
Group III: a beef protein-rich dietExperimental Treatment1 Intervention
High protein diet predominantly provided from lean beef (one 3-oz portion per day; total beef intake 24 oz/week). The energy content of the additional protein foods will be isocalorically offset by substitution for low-protein foods.

Find a Location

Who is running the clinical trial?

National Cattlemen's Beef AssociationOTHER
24 Previous Clinical Trials
1,061 Total Patients Enrolled
2 Trials studying Sarcopenia
63 Patients Enrolled for Sarcopenia
Purdue UniversityLead Sponsor
222 Previous Clinical Trials
72,607 Total Patients Enrolled
3 Trials studying Sarcopenia
82 Patients Enrolled for Sarcopenia
Chad Carroll, PhDPrincipal InvestigatorPurdue University

Media Library

Resistance Training Clinical Trial Eligibility Overview. Trial Name: NCT04347447 — N/A
Sarcopenia Research Study Groups: normal protein diet, a beef protein-rich diet, a protein-rich diet non-red meat
Sarcopenia Clinical Trial 2023: Resistance Training Highlights & Side Effects. Trial Name: NCT04347447 — N/A
Resistance Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT04347447 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are any individuals aged 35 and older being considered for this clinical trial?

"This specific study only allows for applicants in the age range of 60 to 80 years old. However, there are two trials accommodating those under 18 and 337 studies that accept individuals over 65."

Answered by AI

Who fulfills the eligibility criteria for this research endeavor?

"This clinical trial necessitates that patients between the ages of 60 and 80 have sarcopenia. Approximately 45 participants are being accepted into this study."

Answered by AI

Are there any vacancies left for individuals to join this experiment?

"The clinical trial is still open for enrollment, per the details posted on clinicaltrials.gov. The initial posting was made on May 1st 2020 and the most recent edit occurred on May 31st 2022."

Answered by AI

How many participants are currently taking part in this clinical trial?

"Affirmative. The information on clinicaltrials.gov confirms that recruitment for this trial is still ongoing, having first been published on May 1st 2020 and last updated a few weeks ago at the end of May 2022. A total of 45 patients are needed from one single location."

Answered by AI

What are the key goals of this medical experiment?

"The primary outcome measure for this trial, to be observed one week prior to and after the intervention, is Tendon Connective Tissue Stiffness. Secondary measures consist of Blood Cholesterol Assay, Total Triglyceride Levels Assessment and Blood Glucose Analysis."

Answered by AI
~9 spots leftby Mar 2025